scholarly article | Q13442814 |
P50 | author | Yeong Wook Song | Q59822090 |
You-Jung Ha | Q60327690 | ||
Eun Ha Kang | Q88942838 | ||
Yun Jong Lee | Q89612254 | ||
P2093 | author name string | Dong Woo Han | |
Sang Wan Chung | |||
Ji Hyoun Kim | |||
P2860 | cites work | Biology of RANK, RANKL, and osteoprotegerin | Q21195419 |
Suppression of bone formation by osteoclastic expression of semaphorin 4D | Q24294299 | ||
A Tale of Two Joints: The Role of Matrix Metalloproteases in Cartilage Biology | Q26740406 | ||
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
Early biomarkers of joint damage in rheumatoid and psoriatic arthritis | Q28083506 | ||
The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules | Q28118665 | ||
Involvement of CD100, a lymphocyte semaphorin, in the activation of the human immune system via CD72: implications for the regulation of immune and inflammatory responses | Q28189775 | ||
Increased surface expression of a newly identified 150-kDa dimer early after human T lymphocyte activation | Q28276903 | ||
The pathogenesis of rheumatoid arthritis | Q29614957 | ||
Semaphorins guide the entry of dendritic cells into the lymphatics by activating myosin II | Q30498266 | ||
Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort | Q31038073 | ||
How to read radiographs according to the Sharp/van der Heijde method. | Q33544536 | ||
The links between joint damage and disability in rheumatoid arthritis | Q33867923 | ||
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis | Q34315745 | ||
Decreased semaphorin3A expression correlates with disease activity and histological features of rheumatoid arthritis | Q34560081 | ||
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial | Q34651182 | ||
Clinical predictors of erosion-free status in rheumatoid arthritis: a prospective cohort study | Q35096891 | ||
Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis | Q35555021 | ||
The Involvement of Immune Semaphorins in the Pathogenesis of Inflammatory Bowel Diseases (IBDs). | Q35610857 | ||
Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis | Q35617594 | ||
Radiological damage in patients with rheumatoid arthritis on sustained remission | Q35759974 | ||
Studies on ageing and the severity of radiographic joint damage in rheumatoid arthritis | Q35990362 | ||
Semaphorin 3A is a marker for disease activity and a potential immunoregulator in systemic lupus erythematosus | Q36246136 | ||
Serum Sema4D levels are associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis | Q36317974 | ||
Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications. | Q37275562 | ||
Semaphorin 3A in Ankylosing Spondylitis. | Q38665781 | ||
Baseline RANKL:OPG ratio and markers of bone and cartilage degradation predict annual radiological progression over 11 years in rheumatoid arthritis. | Q39936079 | ||
Osteoprotection by semaphorin 3A. | Q41791623 | ||
Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies | Q41918491 | ||
Adenovirus-mediated delivery of Sema3A alleviates rheumatoid arthritis in a serum-transfer induced mouse model | Q42371628 | ||
Association between high plasma levels of hepatocyte growth factor and progression of radiographic damage in the joints of patients with rheumatoid arthritis | Q43500734 | ||
Sustained beneficial effects of a protocolized treat-to-target strategy in very early rheumatoid arthritis: three-year results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort | Q45078242 | ||
Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis | Q46458365 | ||
RANK-Independent Osteoclast Formation and Bone Erosion in Inflammatory Arthritis | Q46515547 | ||
The role of semaphorins in immune responses and autoimmune rheumatic diseases | Q47321853 | ||
The class IV semaphorin CD100 plays nonredundant roles in the immune system: defective B and T cell activation in CD100-deficient mice | Q49157483 | ||
Semaphorin signaling in bone. | Q50936117 | ||
The association between semaphorin 3A levels and gluten-free diet in patients with celiac disease. | Q51002729 | ||
Serum Sema3A is in a weak positive association with bone formation marker osteocalcin but not related to bone mineral densities in postmenopausal women. | Q51318541 | ||
Semaphorin 4D levels in heart failure patients: a potential novel biomarker of acute heart failure? | Q51741939 | ||
High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. | Q51752129 | ||
Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis. | Q53258549 | ||
The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis. | Q54407326 | ||
Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. | Q54528928 | ||
The Role of Semaphorin 4D in Bone Remodeling and Cancer Metastasis. | Q55405777 | ||
Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcome | Q56974114 | ||
Requirement for the lymphocyte semaphorin, CD100, in the induction of antigen-specific T cells and the maturation of dendritic cells | Q74500047 | ||
Dickkopf-1 is a master regulator of joint remodeling | Q79610564 | ||
Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function | Q82097189 | ||
Baseline anti-citrullinated peptide antibody (ACPA) titers and serum interleukin-6 (IL-6) levels possibly predict progression of bone destruction in early stages of rheumatoid arthritis (ERA) | Q83762288 | ||
Interleukin 22 serum levels are associated with radiographic progression in rheumatoid arthritis | Q84142069 | ||
Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression | Q85062679 | ||
Baseline serum interleukin-34 levels independently predict radiographic progression in patients with rheumatoid arthritis | Q87401233 | ||
Expression of circulating Semaphorin3A and its association with inflammation and bone destruction in rheumatoid arthritis | Q88361933 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | molecular biology | Q7202 |
rheumatoid arthritis | Q187255 | ||
P304 | page(s) | 2318386 | |
P577 | publication date | 2018-11-14 | |
P1433 | published in | Disease Markers | Q15756044 |
P1476 | title | Circulating Semaphorin 4D as a Marker for Predicting Radiographic Progression in Patients with Rheumatoid Arthritis | |
P478 | volume | 2018 |